Rebecca D. Jackson

Rebecca D. Jackson is a medical researcher, medical practitioner and professor of endocrinology, diabetes and metabolism. Her research has been significant in the understanding and treatment of osteoporosis.[1] She also researches the opioid crisis in Ohio.[2]

Rebecca D. Jackson
Born1955 (1955)
Alma materOhio State University
Known forWomen's Health Initiative
AwardsMember of the Ohio Women's Hall of Fame; Ohio Woman of the Year; Best Doctor in America
Scientific career
Fieldswomen's health and endocrinology

Jackson is director of the Center for Women's Health, the founding director of the Ohio State University Center for Clinical and Translational Science, associate dean for Clinical and Translational Research, and professor of Endocrinology, Diabetes, and Metabolism at the Ohio State University.[3][4] In 2008, she was elected as a Fellow of the American Association for the Advancement of Science and received the OSU Distinguished Scholar Award, one of Ohio State University's highest research honors, in 2015.

Education

Jackson received her medical degree from Ohio State University College of Medicine in 1978.[5]

Career

Jackson was involved in one of the first studies to show that weight lifting, rather than walking, is more beneficial for maintaining bone density: that the ideal exercise to stimulate bone formation is force rather than repetition. She and her colleagues have also been involved in one of the landmark studies examining bisphosphonates, a new class of medications for treating postmenopausal osteoporosis.[1] She has co-authored hundreds of articles that have appeared in publications including American Journal of Preventive Medicine, Arthritis & Rheumatology, Nature, and Nature Communications.[6]

Jackson's research is concentrated in the area of women's health, with a specific focus on defining clinical factors, biomarkers, and genetic associations for diseases that disproportionately affect women (particularly osteoporosis).[7] Her laboratory has had continuous NIH funding for almost 30 years and she has authored or co-authored more than 250 peer-reviewed manuscripts, including the landmark Women's Health Initiative (WHI) Calcium Plus Vitamin D Trial.[3][8] She was the vice-chair of the WHI, and is now the principal investigator for the WHI Midwest Regional Field Center.[9] Her work focuses on the epidemiology of chronic disease in women, including cancer, osteoporosis, cardiovascular disease and osteoarthritis.[6]

In 2019, Jackson became the lead investigator on a $65 million research study to help reduce deaths from opioid use.[2]

Jackson spends about thirty percent of her time as a clinician and seventy percent as a researcher.[1] She currently practices at the Center for Women's Health in Columbus, Ohio.[5]

Injury

Jackson had a spinal cord injury in the late 1970s and has used a wheelchair since then.[1]

Notable achievements

Jackson's work in the field of medicine has resulted in a number of awards and honors:

References
  1. "biography - Rebecca Jackson, MD (Ohio)". wayback.archive-it.org. Archived from the original on 2019-05-08.
  2. Wehrman, Jessica. "Ohio State to lead $65.9 million state study to help reduce opioid deaths". The Columbus Dispatch. Retrieved 2020-04-23.
  3. "Rebecca D. Jackson, M.D." Office of Disease Prevention.
  4. "Opioid addiction study to begin work in Ohio communities". Ohio State News. Retrieved 2020-04-23.
  5. "Rebecca Jackson". wexnermedical.osu.edu.
  6. "Dr. Rebecca D Jackson - Cancer Researcher at OSUCCC - James". The James - OSUCCC.
  7. "Anti-inflammatory diet could reduce risk of bone loss in women: Study also found diet linked to fewer hip fractures in younger white women". ScienceDaily. Retrieved 2020-04-23.
  8. Lessons From WHI, Part 4: The Trial That Keeps on Giving, retrieved 2020-04-23
  9. "Rebecca Jackson, MD I Ohio State Neurological Institute". wexnermedical.osu.edu. Retrieved 2020-04-23.
  10. "Rebecca Jackson". wexnermedical.osu.edu. Retrieved 2020-04-23.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.